Health systems generate the data and clinical insights driving AI breakthroughs but rarely share in resulting profits. A new collaborative model could change that.
Healthcare institutions face a fundamental economic paradox: they identify the clinical problems AI could solve, supply the training data that powers these systems, validate emerging technologies in real-world settings, and bear the implementation risks. Yet when those AI companies succeed, the financial gains flow almost entirely to technology firms and their investors.
This pattern reflects what some healthcare leaders describe as a structural market failure. According to Becker's Hospital Review, health systems contribute the essential ingredients for innovation success but receive minimal equity stakes or revenue participation in return, typically amounting to little more than ongoing software licensing fees.
The Fragmentation Problem
The core issue extends beyond unfair profit distribution. Hospital networks operate in isolation, each independently piloting AI tools, negotiating separately with vendors, and learning lessons in silos. This fragmentation creates massive inefficiency. Multiple health systems spend resources solving identical problems, weakening their collective purchasing power and slowing the adoption of proven AI applications across the industry.
As artificial intelligence development accelerates, this decentralized model becomes increasingly costly. The pace of AI innovation now outstrips any single institution's ability to evaluate and integrate new tools effectively. What was once workable is becoming untenable.
Why AI Amplifies the Challenge
Artificial intelligence presents both opportunity and urgency. AI tools can dramatically reduce the time and expense required to develop new clinical applications. But this abundance of new solutions creates a new scarcity: the organizational capacity to identify which tools address genuine clinical needs, integrate them into existing workflows, and safely scale them across complex healthcare networks.
In this environment, AI cannot remain a peripheral strategic initiative. It must become embedded across clinical departments, operational functions, and service lines. This level of integration requires coordinated effort across organizations, not within them.
The Cooperative Advantage Model
Healthcare leaders propose shifting from a competitive hoarding mindset to what they call a "Cooperative Advantage." This model envisions a Learning Health Economy in which health systems:
Collectively identify shared clinical and operational challenges
Pool capital for AI development and validation
Share implementation insights openly across the network
Coordinate AI adoption timelines
Participate directly in the economic value created by the companies they help build
This differs fundamentally from traditional venture funding or group purchasing agreements. It represents an institutional redesign intended to realign incentives across the entire healthcare innovation ecosystem: health systems, entrepreneurs, investors, clinicians, and patients would share a common purpose rather than competing over capture of innovation value.
The stakes are substantial. As AI penetrates healthcare more deeply, the question of who captures the value generated by AI breakthroughs will shape the industry's trajectory. A fragmented approach will likely perpetuate current patterns, with hospitals funding innovation through data and expertise while remaining economically marginal to the companies they create. Collaborative networks could fundamentally restructure that relationship.
This article was originally published on AI Glimpse.
Top comments (0)